| Line 33: | Line 33: | ||
===2021: [https://link.springer.com/article/10.1007/s11739-021-02674-3 Health outcomes in COPD smokers using heated tobacco products: a 3-year follow-up]=== | ===2021: [https://link.springer.com/article/10.1007/s11739-021-02674-3 Health outcomes in COPD smokers using heated tobacco products: a 3-year follow-up]=== | ||
* This study is the first to describe the long-term health effects of HTP use in COPD patients. Consistent improvements in respiratory symptoms, exercise tolerance, quality of life, and rate of disease exacerbations were observed in patients with COPD who abstained from smoking or substantially reduced their cigarette consumption by switching to HTP use. | * This study is the first to describe the long-term health effects of HTP use in COPD patients. Consistent improvements in respiratory symptoms, exercise tolerance, quality of life, and rate of disease exacerbations were observed in patients with COPD who abstained from smoking or substantially reduced their cigarette consumption by switching to HTP use. | ||
*Polosa, R., Morjaria, J.B., Prosperini, U. et al. Health outcomes in COPD smokers using heated tobacco products: a 3-year follow-up. Intern Emerg Med 16, 687–696 (2021). https://doi.org/10.1007/s11739-021-02674-3 | *Citation: Polosa, R., Morjaria, J.B., Prosperini, U. et al. Health outcomes in COPD smokers using heated tobacco products: a 3-year follow-up. Intern Emerg Med 16, 687–696 (2021). https://doi.org/10.1007/s11739-021-02674-3 | ||
===2021: [https://link.springer.com/article/10.1007/s11739-021-02798-6 Changes in biomarkers after 180 days of tobacco heating product use: a randomised trial]=== | ===2021: [https://link.springer.com/article/10.1007/s11739-021-02798-6 Changes in biomarkers after 180 days of tobacco heating product use: a randomised trial]=== | ||
edits